Methyl-CpG Binding Protein 2 in Alzheimer Dementia
Despite decades of research on Alzheimer disease, understanding the complexity of the genetic and molecular interactions involved in its pathogenesis remains far from our grasp. Methyl-CpG Binding Protein 2 (MeCP2) is an important epigenetic regulator enriched in the brain, and recent findings have...
Main Authors: | Baeksun Kim, Yunjung Choi, Hye-Sun Kim, Heh-In Im |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Continence Society
2019-11-01
|
Series: | International Neurourology Journal |
Subjects: | |
Online Access: | http://www.einj.org/upload/pdf/inj-1938196-098.pdf |
Similar Items
-
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
by: Shervin Pejhan, et al.
Published: (2021-01-01) -
The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology
by: Kazem Nejati-Koshki, et al.
Published: (2023-05-01) -
Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia
by: Chia-Hsiang Chen, et al.
Published: (2020-05-01) -
Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study
by: Suzanne Cassel, et al.
Published: (2004-03-01) -
Lovastatin fails to improve motor performance and survival in methyl-CpG-binding protein2-null mice
by: Claudia Villani, et al.
Published: (2016-11-01)